266
Views
3
CrossRef citations to date
0
Altmetric
Systematic Review

Soy isoflavone intake and risk of cardiovascular disease in adults: A systematic review and dose-response meta-analysis of prospective cohort studies

, , , , , & show all

References

  • Aslani, Z., O. Sadeghi, M. Heidari-Beni, H. Zahedi, F. Baygi, N. Shivappa, J. R. Hébert, S. Moradi, G. Sotoudeh, H. Asayesh, et al. 2020. Association of dietary inflammatory potential with cardiometabolic risk factors and diseases: A systematic review and dose-response meta-analysis of observational studies. Diabetology & Metabolic Syndrome 12:86. doi: 10.1186/s13098-020-00592-6.
  • Blekkenhorst, L., M. Sim, C. Bondonno, N. Bondonno, N. Ward, R. Prince, A. Devine, J. Lewis, and J. Hodgson. 2018. Cardiovascular health benefits of specific vegetable types: A narrative review. Nutrients 10 (5). doi: 10.3390/nu10050595.
  • Chan, Y.-H., K.-K. Lau, K.-H. Yiu, C.-W. Siu, H.-T. Chan, S.-W. Li, S. Tam, T.-H. Lam, C.-P. Lau, and H.-F. Tse. 2012. Prospective observational study of isoflavone and the risk of stroke recurrence: Potential clinical implications beyond vascular function. The Journal of Nutrition, Health & Aging 16 (4):383–8. doi: 10.1007/s12603-012-0048-6.
  • Curtis, P. J., M. Sampson, J. Potter, K. Dhatariya, P. A. Kroon, and A. Cassidy. 2012. Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: A 1-year, double-blind, randomized, controlled trial. Diabetes Care 35 (2):226–32. doi: 10.2337/dc11-1443.
  • D'Alessandro, A., and G. De Pergola. 2018. The mediterranean diet: Its definition and evaluation of a priori dietary indexes in primary cardiovascular prevention. International Journal of Food Sciences and Nutrition 69 (6):647–59. doi: 10.1080/09637486.2017.1417978.
  • DerSimonian, R., and N. Laird. 1986. Meta-analysis in clinical trials. Controlled Clinical Trials 7 (3):177–88. doi: 10.1016/0197-2456(86)90046-2.
  • Egger, M., G. Davey Smith, M. Schneider, and C. Minder. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research ed.) 315 (7109):629–34. doi: 10.1136/bmj.315.7109.629.
  • Graf, B. A., P. E. Milbury, and J. B. Blumberg. 2005. Flavonols, flavones, flavanones, and human health: Epidemiological evidence. Journal of Medicinal Food 8 (3):281–90. doi: 10.1089/jmf.2005.8.281.
  • Greenland, S., and M. P. Longnecker. 1992. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. American Journal of Epidemiology 135 (11):1301–9. doi: 10.1093/oxfordjournals.aje.a116237.
  • Higgins, J. P., and S. Green. 2008. Cochrane handbook for systematic reviews of interventions. Chichester; Hoboken, NJ: Wiley-Blackwell.
  • Im, J., and K. Park. 2021. Association between soy food and dietary soy isoflavone intake and the risk of cardiovascular disease in women: A prospective cohort study in Korea. Nutrients 13 (5):1407. doi: 10.3390/nu13051407.
  • Kokubo, H., J. Iso, K. Ishihara, M. Okada, S. Inoue, and Tsugane, Y. 2007. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: The Japan Public Health Center-based (JPHC) study cohort I. Circulation 116 (22):2553–62. doi: 10.1161/circulationaha.106.683755.
  • Kozłowska, A., and D. Szostak-Wegierek. 2014. Flavonoids–food sources and health benefits. Roczniki Panstwowego Zakladu Higieny 65 (2):79–85.
  • Lin, L. 2020. Hybrid test for publication bias in meta-analysis. Statistical Methods in Medical Research 29 (10):2881–99. doi: 10.1177/0962280220910172.
  • Lou, D., Y. Li, G. Yan, J. Bu, and H. Wang. 2016. Soy consumption with risk of coronary heart disease and stroke: A meta-analysis of observational studies. Neuroepidemiology 46 (4):242–52. doi: 10.1159/000444324.
  • Ma, L., G. Liu, M. Ding, G. Zong, F. B. Hu, W. C. Willett, E. B. Rimm, J. E. Manson, and Q. Sun. 2020. Isoflavone intake and the risk of coronary heart disease in US men and women: Results from 3 prospective cohort studies. Circulation 141 (14):1127–37. doi: 10.1161/circulationaha.119.041306.
  • Mansouri, M., F. Sharifi, H. Yaghubi, M. Varmaghani, Y. M. Tabrizi, M. Nasiri, and O. Sadeghi. 2020. Sugar-sweetened beverages consumption in relation to hypertension among Iranian university students: The MEPHASOUS study. Eating and Weight Disorders : EWD 25 (4):973–82. doi: 10.1007/s40519-019-00713-9.
  • McAloon, C. J., L. M. Boylan, T. Hamborg, N. Stallard, F. Osman, P. B. Lim, and S. A. Hayat. 2016. The changing face of cardiovascular disease 2000-2012: An analysis of the world health organisation global health estimates data. International Journal of Cardiology 224:256–64. doi: 10.1016/j.ijcard.2016.09.026.
  • McCullough, M. L., J. J. Peterson, R. Patel, P. F. Jacques, R. Shah, and J. T. Dwyer. 2012. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. The American Journal of Clinical Nutrition 95 (2):454–64. doi: 10.3945/ajcn.111.016634.
  • Messina, M. 2014. Soy foods, isoflavones, and the health of postmenopausal women. The American Journal of Clinical Nutrition 100 Suppl 1 (Suppl 1):423s–30s. doi: 10.3945/ajcn.113.071464.
  • Messina, M. J., and C. E. Wood. 2008. Soy isoflavones, estrogen therapy, and breast cancer risk: Analysis and commentary. Nutrition Journal 7 (1):17. doi: 10.1186/1475-2891-7-17.
  • Micek, A., J. Godos, D. Del Rio, F. Galvano, and G. Grosso. 2021. Dietary flavonoids and cardiovascular disease: A comprehensive dose-response meta-analysis. Molecular Nutrition & Food Research 65 (6):e2001019. doi: 10.1002/mnfr.202001019.
  • Mink, P. J., C. G. Scrafford, L. M. Barraj, L. Harnack, C. P. Hong, J. A. Nettleton, and D. R. Jacobs. Jr 2007. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. The American Journal of Clinical Nutrition 85 (3):895–909. doi: 10.1093/ajcn/85.3.895.
  • Muthyala, R. S., Y. H. Ju, S. Sheng, L. D. Williams, D. R. Doerge, B. S. Katzenellenbogen, W. G. Helferich, and J. A. Katzenellenbogen. 2004. Equol, a natural estrogenic metabolite from soy isoflavones: Convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorganic & Medicinal Chemistry 12 (6):1559–67. doi: 10.1016/j.bmc.2003.11.035.
  • Nachvak, S. M., S. Moradi, J. Anjom-Shoae, J. Rahmani, M. Nasiri, V. Maleki, and O. Sadeghi. 2019. Soy, soy isoflavones, and protein intake in relation to mortality from all causes, cancers, and cardiovascular diseases: A systematic review and dose-response meta-analysis of prospective cohort studies. Journal of the Academy of Nutrition and Dietetics 119 (9):1483–500.e17. e1417. doi: 10.1016/j.jand.2019.04.011.
  • Nagata, C., K. Wada, T. Tamura, K. Konishi, Y. Goto, S. Koda, T. Kawachi, M. Tsuji, and K. Nakamura. 2017. Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: The Takayama study. The American Journal of Clinical Nutrition 105 (2):426–31. doi: 10.3945/ajcn.116.137281.
  • Nestel, P. J., T. Yamashita, T. Sasahara, S. Pomeroy, A. Dart, P. Komesaroff, A. Owen, and M. Abbey. 1997. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology 17 (12):3392–8. doi: 10.1161/01.ATV.17.12.3392.
  • Nozue, M., T. Shimazu, H. Charvat, N. Mori, M. Mutoh, N. Sawada, M. Iwasaki, T. Yamaji, M. Inoue, Y. Kokubo, et al. 2021. Fermented soy products intake and risk of cardiovascular disease and total cancer incidence: The Japan Public Health Center-based Prospective study. European Journal of Clinical Nutrition 75 (6):954–68. doi: 10.1038/s41430-020-00732-1.
  • Orsini, N., R. Bellocco, and S. Greenland. 2006. Generalized least squares for trend estimation of summarized dose–response data. The Stata Journal: Promoting Communications on Statistics and Stata 6 (1):40–57. doi: 10.1177/1536867X0600600103.
  • Page, M. J., J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, J. M. Tetzlaff, E. A. Akl, S. E. Brennan, et al. 2021. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ (Clinical Research ed.) 372:n71. doi: 10.1136/bmj.n71.
  • Parohan, M., J. Anjom-Shoae, M. Nasiri, M. Khodadost, S. R. Khatibi, and O. Sadeghi. 2019. Dietary total antioxidant capacity and mortality from all causes, cardiovascular disease and cancer: A systematic review and dose-response meta-analysis of prospective cohort studies. European Journal of Nutrition 58 (6):2175–89. doi: 10.1007/s00394-019-01922-9.
  • Parohan, M., A. Sadeghi, M. Nasiri, V. Maleki, M. Khodadost, A. Pirouzi, and O. Sadeghi. 2019. Dietary acid load and risk of hypertension: A systematic review and dose-response meta-analysis of observational studies. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD 29 (7):665–75. doi: 10.1016/j.numecd.2019.03.009.
  • Ponzo, V., I. Goitre, M. Fadda, R. Gambino, A. De Francesco, L. Soldati, L. Gentile, P. Magistroni, M. Cassader, and S. Bo. 2015. Dietary flavonoid intake and cardiovascular risk: A population-based cohort study. Journal of Translational Medicine 13:218. doi: 10.1186/s12967-015-0573-2.
  • Ravera, A., V. Carubelli, E. Sciatti, I. Bonadei, E. Gorga, D. Cani, E. Vizzardi, M. Metra, and C. Lombardi. 2016. Nutrition and cardiovascular disease: Finding the perfect recipe for cardiovascular health. Nutrients 8 (6):363. doi: 10.3390/nu8060363.
  • Saeed, A., J. Kampangkaew, and V. Nambi. 2017. Prevention of cardiovascular disease in Women. Methodist DeBakey Cardiovascular Journal 13 (4):185–92. doi: 10.14797/mdcj-13-4-185.
  • Stang, A. 2010. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology 25 (9):603–5. doi: 10.1007/s10654-010-9491-z.
  • Taku, K., N. Lin, D. Cai, J. Hu, X. Zhao, Y. Zhang, P. Wang, M. K. Melby, L. Hooper, M. S. Kurzer, et al. 2010. Effects of soy isoflavone extract supplements on blood pressure in adult humans: Systematic review and meta-analysis of randomized placebo-controlled trials. Journal of Hypertension 28 (10):1971–82. doi: 10.1097/HJH.0b013e32833c6edb.
  • Talaei, M., W. P. Koh, R. M. van Dam, J. M. Yuan, and A. Pan. 2014. Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. The Journal of Nutrition 144 (6):921–8. doi: 10.3945/jn.114.190454.
  • Tavani, A., L. Spertini, C. Bosetti, M. Parpinel, P. Gnagnarella, F. Bravi, J. Peterson, J. Dwyer, P. Lagiou, E. Negri, et al. 2006. Intake of specific flavonoids and risk of acute myocardial infarction in Italy. Public Health Nutrition 9 (3):369–74. doi: 10.1079/phn2006859.
  • van der Schouw, Y. T., S. Kreijkamp-Kaspers, P. H. Peeters, L. Keinan-Boker, E. B. Rimm, and D. E. Grobbee. 2005. Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation 111 (4):465–71. doi: 10.1161/01.cir.0000153814.87631.b0.
  • Yan, Z., X. Zhang, C. Li, S. Jiao, and W. Dong. 2017. Association between consumption of soy and risk of cardiovascular disease: A meta-analysis of observational studies. European Journal of Preventive Cardiology 24 (7):735–47. doi: 10.1177/2047487316686441.
  • Yari, Z., H. Tabibi, I. Najafi, M. Hedayati, and M. Movahedian. 2020. Effects of soy isoflavones on serum systemic and vascular inflammation markers and oxidative stress in peritoneal dialysis patients: A randomized controlled trial. Phytotherapy Research : PTR 34 (11):3011–8. doi: 10.1002/ptr.6729.
  • Yu, D., X.-O. Shu, H. Li, G. Yang, Q. Cai, Y.-B. Xiang, B.-T. Ji, A. A. Franke, Y.-T. Gao, W. Zheng, et al. 2015. Dietary isoflavones, urinary isoflavonoids, and risk of ischemic stroke in women. The American Journal of Clinical Nutrition 102 (3):680–6. doi: 10.3945/ajcn.115.111591.
  • Yu, D., X. Zhang, Y.-B. Xiang, G. Yang, H. Li, S. Fazio, M. Linton, Q. Cai, W. Zheng, Y.-T. Gao, et al. 2014. Association of soy food intake with risk and biomarkers of coronary heart disease in Chinese men. International Journal of Cardiology 172 (2):e285–287. doi: 10.1016/j.ijcard.2013.12.200.
  • Zahradka, P., B. Wright, W. Weighell, H. Blewett, A. Baldwin, K. O, R. P. Guzman, and C. G. Taylor. 2013. Daily non-soy legume consumption reverses vascular impairment due to peripheral artery disease. Atherosclerosis 230 (2):310–4. doi: 10.1016/j.atherosclerosis.2013.07.048.
  • Zamora-Ros, R., C. Jiménez, R. Cleries, A. Agudo, M.-J. Sánchez, E. Sánchez-Cantalejo, E. Molina-Montes, C. Navarro, M.-D. Chirlaque, J. María Huerta, et al. 2013. Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology (Cambridge, Mass.) 24 (5):726–33. doi: 10.1097/EDE.0b013e31829d5902.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.